Drug discovery in neurodegenerative diseases.
This meeting report documents the exciting ongoing research aimed at developing new therapeutic agents for neurodegenerative diseases at the interface between academia and industry, and illustrates the direction the NIH "roadmap" for medical research is taking. Some of the projects have resulted in very promising drugs, identified and developed by academic centers, entering clinical trials.
Geerts
Hugo
H
In Silico Biosciences, Center for Neurodegenerative Disease Research, Institute on Aging, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. Hugo-Geerts@In-Silico-Biosciences.com
Trojanowski
John Q
JQ
Lee
Virginia M-Y
VM
D000682:Amyloid / Q000737:chemistry; D000818:Animals; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D015195:Drug Design; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D009462:Neurology / Q000639:trends; D009480:Neuropharmacology / Q000639:trends*; D017510:Protein Folding
D000682:Amyloid